ISSN 1006-298X      CN 32-1425/R

导航

肾脏病与透析肾移植杂志 ›› 2022, Vol. 31 ›› Issue (1): 21-25.DOI: 10.3969/j.issn.1006-298X.2022.01.004

• • 上一篇    下一篇

抗中性粒细胞胞质抗体相关性肾炎患者的妊娠结局

  

  • 出版日期:2022-02-28 发布日期:2022-02-18

Pregnancy outcomes in patients with antineutrophil cytoplasmic antibodyassociated glomerulonephritis

  • Online:2022-02-28 Published:2022-02-18

摘要: 目的:通过对5例抗中性粒细胞胞质抗体(ANCA)相关肾炎(AAGN)患者共7次妊娠的随访,探讨AAGN患者的妊娠合并症和胎儿结局及其影响因素。
方法:5例抗髓过氧化酶(MPO)ANCA阳性AAGN女性患者,在获得肾脏缓解后妊娠。孕期给予激素或联合硫唑嘌呤维持,血管炎活动性采用伯明翰血管炎活动评分(BVAS)评分。患者妊娠并发症包括AAGN复发、妊娠高血压、慢性肾脏病(CKD)进展或急性肾损伤;胎儿不良结局包括早产、胎儿丢失和胎儿宫内发育迟缓(IUGR)等。
结果:5例AAGN患者共妊娠7次(2例患者妊娠2次)。妊娠前中位AAGN病程60(34,125)月,肾脏缓解时间32(15,75)月,尿蛋白≤05g/24h,估计的肾小球滤过率(eGFR)均>60 ml/(min·173m2),4例次血清MPOANCA阳性(1例高滴度阳性)。孕期6例次激素治疗,1例次激素联合硫唑嘌呤。7次妊娠中4次无妊娠相关并发症,胎儿足月生产;3次出现母体并发症或不良胎儿结局(分别为孕期严重高血压并提前终止妊娠,子痫前期伴胎儿IUGR及早产,及孕前MPOANCA高滴度阳性者AAGN复发)。产下6个新生儿均存活。产后中位随访22月,1例产后1月AAGN复发(孕期MPOANCA持续低滴度阳性),1例孕期复发患者由CKD 2期进展至CKD 3期,
1例孕前高血压且妊娠2次的患者由CKD1期进展至CKD 4期。
结论:肾脏缓解的女性AAGN患者可以成功妊娠,但对血清ANCA阳性和高血压患者应加强干预以降低AAGN复发、肾功能恶化和妊娠不良结局的风险。


关键词: 抗中性粒细胞胞质抗体相关性肾炎, 抗髓过氧化酶-抗中性粒细胞胞质抗体, 妊娠结局, 胎儿

Abstract: Objective:To discuss the pregnancy outcomes and influence factors in patients with antineutrophil cytoplasmic antibody—associated glomerulonephritis (AAGN).
Methodology:Five women with MPOANCA positive AAGN who achieved complete renal remission were collected in our unit. Prednisone or prednisone combined azathioprine (AZA) was administered during pregnancy. Vasculitis activity was scored by BVAS. Pregnancyrelated complications included relapse of AAGN, gestational hypertension, progression of chronic kidney disease (CKD), or acute kidney injury. Adverse fetal outcomes include premature delivery, fetal loss, and intrauterine growth retardation (IUGR).
Results:We described 7 pregnancies in 5 patients who were all in remission at conception,and the mean time to renal remission was 32 months. EGFR of all the patients before pregnancy was more than 60 ml/(min·173m2), and proteinuria was less than 05 g/24h. Serum MPOANCA was positive in 4 pregnancies, and one with hypertension before pregnancy. Six pregnancies were maintained with prednisone monotherapy and one with prednisone combined AZA. 4 of the 7 pregnancies were no pregnancyrelated complications and the fetuses were delivered to term, and the other 3 pregnancies were with fetal or maternal complications (including one with severe hypertension in pregnancy and termination of pregnancy at 8 weeks, one with preeclampsia and fatal premature delivery, one experiencing a relapse during pregnancy with positive serum MPOANCA before pregnancy). The median followup after the last conception was 22 months, one patient experienced a relapse after conception, and the patient with hypertension before pregnancy progressed from CKD stage 1 to CKD stage 4.
Conclusion:Patients in remission of AAGN at conception can have a successful pregnancies, but MPOANCA positive increases the risk of recurrence, hypertension increases the risk of fetal adverse outcomes and the progression of CKD.


Key words: ANCA-associated glomerulonephritis, MPO-ANCA, pregnancy outcome fatal